12:00 AM
Dec 20, 2010
 |  BC Week In Review  |  Company News  |  Management Tracks

Valeant Pharmaceuticals board of directors update

Valeant Pharmaceuticals International Inc. (NYSE:VRX; TSX:VRX), Mississauga, Ontario
Business: Neurology, Dermatology...

Read the full 34 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >